Ringing the infamous bell at the New York Stock Exchange (NYSE) is a once-in-a-lifetime opportunity. The chance to close the markets for Tracy Clifford, CFO of Pernix Therapeutics Holdings, Inc. (PTX) and a finance adjunct professor in the School of Business, will happen this week. She will join Cooper C. Collins, the Company’s CEO, who accepted an invitation from the NYSE Amex to ring the closing bell on January 12, 2011 at 4 p.m.
Tune into CNBC or other live media that broadcasts the closing bell to see Clifford at the podium this Wednesday.
In addition to her role as CFO, Clifford teaches personal finance (FINC-120) in the School of Business. She joined the School in 2007 when she accepted the position to design and manage the curriculum for the Department of Economics and Finance’s internship program. As a 1991 alumnus of the College, Clifford is an avid Cougars fan. She enthusiastically volunteers for various efforts in support of the Cougar baseball program and attends as many basketball games as possible.
“The School is fortunate to have such experienced financial professionals as Tracy on our faculty. She brings her wealth of perspective in working for a publicly traded pharmaceutical company to the classroom in ways that truly benefit our students and peer faculty,” says Kent Gourdin, associate dean of undergraduate studies in the School of Business.
As a busy mom with a young family, Clifford enjoys the advantages a virtual corporate headquarters that Pernix has adopted. It’s a cutting edge workplace environment and infrastructure that hires the best people who fit into the corporate culture.
“Working for Pernix is an invaluable experience. The CFO position of a public company is challenging but also rewarding. Since I am originally from Charleston, I am thrilled that after having built my career in Miami and Atlanta that I could come back and enjoy the quality of life here in Charleston but still enjoy the benefits of a challenging career,” says Clifford.
About the School of Business
College of Charleston’s School of Business offers five undergraduate programs, an honors program, an M.S. in Accountancy and an MBA. Approximately 1800 undergraduate and graduate students attend from as far away as China, Germany and Brazil. The faculty has research expertise in areas such as global logistics, hospitality and tourism, political economics, financial investment, bankruptcy, business intelligence, and sustainable business practices. Visit sb.cofc.edu to learn more.
About Pernix Therapeutics
Pernix Therapeutics Holdings, Inc. is an integrated specialty pharmaceutical company primarily focused on serving the needs of the pediatric marketplace. Commercially-proven branded product families include CEDAX®, Brovex®, Aldex®, Pediatex®, ReZyst®, QuinZyme® and Z-Cof®. The Company was originally founded in 1999 and is based in the Houston, TX metropolitan area. Additional information about Pernix is available on the Company’s website located at www.pernixtx.com.